The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson??s disease
- 1 December 1998
- journal article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 8 (6) , 473???480
- https://doi.org/10.1097/00008571-199812000-00003
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: